Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by mutations in the survival motor neuron 1 (<i>SMN2</i>) gene. All patients have at least one copy of a paralog, <i>SMN2</i>, but a C-to-T transition in this gene results in exon 7 skipping in a majority of tra...
Egile Nagusiak: | Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Cell Press
2021
|
Antzeko izenburuak
-
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
nork: Audrey M. Winkelsas, et al.
Argitaratua: (2021-03-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
nork: Winkelsas, AM
Argitaratua: (2020) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
nork: Bowerman, M, et al.
Argitaratua: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
nork: Bowerman, M, et al.
Argitaratua: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
nork: Melissa Bowerman, et al.
Argitaratua: (2017-08-01)